A monoclonal antibody (M2A, IgG2a) was produced against a cultured human ovarian epithelial adenocarcinoma cell line, HEY. Monoclonal antibody M2A reacted with a glycoprotein of molecular weight 40,000 on the surface of HEY cells. The affinity constant of the monoclonal antibody M2A for HEY cells was 109 M-1, and the number of binding sites on HEY cells was 2 x 104 per cell. The monoclonal antibody produced positive immunoperoxidase staining of fetal (but not adult) testis and of seminomas and dysgerminomas but did not stain various normal adult tissues or other gonadal or extragonadal tumors. Monoclonal antibody M2A may be useful for confirming a histological diagnosis of seminoma and dysgerminoma.
antibody produced positive immunoperoxidase staining of fetal (but not adult) testis and of seminomas and dysgerminomas but did not stain various normal adult tissues or other gonadal or extragonadal tumors. Monoclonal antibody M2A may be useful for confirming a histological diagnosis of seminoma and dysgerminoma.
Seminomas account for approximately 40% of primary testicular tumors, whereas dysgerminomas, their counterpart in women, account for 1-2% of primary ovarian tumors (1, 2) . Embryonal nests of germ cells may also give rise to extragonadal seminomas and dysgerminomas in the mediastinum (3), the retroperitoneum (4) , and the suprasellar region of the brain (5) . Most seminomas have a typical appearance on light microscopy and present no problem in histological diagnosis. However, attempts to confirm a diagnosis of atypical seminomas by immunohistochemical techniques have been frustrated by the lack of antibodies directed against specific antigenic markers associated with seminoma cells (6) (7) (8) . In this communication we report the production of a monoclonal antibody (mAb), M2A, that reacts with fetal but not adult testis, with seminomas, and with dysgerminomas but not with other normal adult tissues or gonadal or extragonadal tumors. Potential applications of this mAb include confirmation of the histological diagnosis of primary and metastatic gonadal and extragonadal seminomas and dysgerminomas.
MATERIALS AND METHODS
Antibodies. Rabbit polyclonal antibodies used were antimouse immunoglobulin (Ig) specific for various subclasses of mouse Ig (Litton Bionetics) and anti-mouse Ig coupled to horseradish peroxidase (Dako, Santa Barbara, CA). Mouse myeloma MOPC 315 IgA and a monoclonal anti-idiotypic antibody (AIA D10) directed against it were prepared as described (9) .
Cell Lines. The human ovarian adenocarcinoma cell line HEY (10) Production of mAb. Eight-week-old female BALB/c mice (Canadian Breeding Laboratories, Montreal, PQ) were immunized intraperitoneally with 2 x 107 cultured HEY cells, followed by a second, similar injection after 30 days. Three days later, splenic lymphocytes were fused with Sp2/0-Agl4 myeloma cells (11) , using polyethylene glycol (PEG 4000) (9) . Hybridoma colonies were selected in hypoxanthine/aminopterin/thymidine medium, using 96-well tissue culture plates (Falcon), and were screened by a cell-binding radioimmunoassay (RIA) (see below) for production of mAb against cultured HEY cells and primary cultures of human fibroblasts. Hybridomas that produced mAb reacting with HEY cells but not with fibroblasts were cloned twice by limiting dilution (9) . To obtain ascitic fluid containing mAb, hybridoma cells were injected intraperitoneally into BALB/c mice primed with 2,6,10,14-tetramethylpentadecane (pristane, ICN). Immunoglobulin was prepared from ascitic fluid by affinity chromatography on protein A-Sepharose (Pharmacia) and concentrated to 1.6 mg/ml in 10 mM sodium phosphate at pH 7.2 (12) .
Cell-Binding RIA. Cultured cells were seeded in 96-well tissue culture plates at a density of 104 cells per well and grown for 4-5 days, at which time they had formed confluent monolayers. They were incubated successively with mAb, rabbit anti-mouse Ig antisera specific for various mouse Ig subclasses, and "25I-labeled protein A, each for 40 min at 37°C (9) . Washes with minimal essential medium alpha were performed between incubations. The cells were dissolved in 2 M NaOH, and collected with a cotton-tipped applicator, and the radioactivity was measured in a gamma counter.
Determination of Characteristics of Binding of mAb M2A to HEY Cells. Monolayers of HEY cells were incubated with various concentrations (7-70 nM) of mAb M2A, followed by a saturating amount of the 1251-labeled (Fab')2 fragment of sheep anti-mouse Ig antibody (Amersham) (13) . The data were plotted in a modified Scatchard form, and the affinity constant of mAb M2A and the number ofbinding sites per cell were calculated (13 
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at which time 4-to 6-Am-thick sections were cut on an American Optical cryostat. After fixation in acetone for 15 min, the sections were rehydrated in Tris/NaCl (5 mM Tris Cl, pH 7.6/150 mM NaCl) and incubated with mAb (ascitic fluid or purified mAb diluted 1:100 in Tris/NaCl), followed by peroxidase-conjugated goat anti-mouse Ig antibody (1:50 dilution), each for 45 min, and finally with 0.05% diaminobenzidine and 0.03% H202 for 4 min. All incubations were at room temperature and all dilutions and rinses between incubations were performed with Tris/NaCl. The sections were counterstained with hematoxylin and mounted under coverslips for viewing by light microscopy.
Use 200 ,ul of a 1-mg/ml solution of lactoperoxidase (Sigma) and 1 mCi of carrier-free 1251 (Amersham). Three 50-,ul aliquots of 0.03% H202 were added at 3-min intervals. Ten minutes after the last addition, the monolayers were washed three times with PBS containing 5 mM Lcysteine.
After metabolic or surface labeling, the monolayers were harvested and washed twice with PBS by centrifugation. The cell pellets were lysed by Vortex mixing at room temperature in 1 ml of 50 mM Tris Cl, pH 7.2/150 mM NaCl/1% (vol/vol) Triton X-100/1% deoxycholate/0.1% NaDodSO4/1 mM phenylmethylsulfonyl fluoride. The cell lysates were centrifuged at 100,000 x g for 60 min. The supernatants were incubated with 200 ,ul of a 10% (wt/vol) suspension of protein A-Sepharose beads for 1 hr at 4°C. The beads were removed by centrifugation and the total radioactivity incorporated into proteins was determined by scintillation counting after precipitation in 10% (wt/vol) trichloroacetic acid at 90°C. Ali- proteins were released from the protein A-Sepharose by boiling for 5 min in 100 1.l of 1% NaDodSO4/2% 2-mercaptoethanol and analyzed by polyacrylamide gel electrophoresis (PAGE) and autoradiography, as described (9) .
RESULTS
Binding of mAb M2A to Cultured Cells. mAb M2A was obtained in a fusion experiment using spleen cells of a mouse immunized with the HEY cell line and was selected on the basis of reactivity in a cell-binding RIA with HEY cells but not with primary cultures of human fibroblasts (Fig. 1) . mAb M2A reacted with rabbit anti-mouse IgG2a antibody in an indirect cell-binding RIA but not with rabbit antibodies specific for other mouse Ig subclasses, indicating that it was of the IgG2a subclass. A modified Scatchard plot of binding of mAb M2A to HEY cells is shown in Fig. 2 13. tumors was assayed using cryostat sections and an immunoperoxidase reaction (Table 1) . mAb M2A reacted with germ cells in the seminiferous tubules of a fetal (24 weeks of gestation) testis (Fig. 3A) but not with germ cells or sustentacular cells of normal seminiferous tubules in adult testis. Tumor cells of 12 classical testicular seminomas stained positively, as did seminoma cells infiltrating seminiferous tubules. In contrast, lymphocytes between the seminoma cells did not stain (Fig. 3 C-F) . No other type of testicular tumor reacted with mAb M2A (Table 1) . The mAb reacted with three primary ovarian dysgerminomas but not with normal adult ovary or the other ovarian tumors tested (Table 1 ). In addition to reactivity with testicular seminomas and ovarian dysgerminomas, there was less intense staining i r. (Fig. 4B) , and it was localized to the surface of HEY cells on the basis of its accessibility to enzymatic radioiodination by lactoperoxidase (Fig. 4C ). DISCUSSION mAb M2A was shown in the present study to react with an oncofetal antigen shared by the germ cells of seminiferous tubules of immature testis and the tumor cells of seminomas and dysgerminomas. Mesothelial cells and vascular endothelium also showed slight reactivity with the mAb (Fig. 3) . This crossreactivity implies that mesothelial cells and vascular endothelium bear an epitope similar to one on the surface of the seminoma cells. The significance ofthis, including whether this epitope is part of the same macromolecule in different tissues, remains to be determined. Although mAb M2A was raised against and reacted in an immunoperoxidase reaction with the epithelial ovarian adenocarcinoma cell line HEY, it did not react with other epithelial adenocarcinomas of the ovary or normal adult ovary (Table 1 ). In a previous study, mAb M2A was also shown not to react with the original HEY ovarian adenocarcinoma xenograft grown in thymectomized CBA/CJ mice, from which the HEY cell line was derived (unpublished data).
This antigenic difference was assumed to be due to selection of a rare stem cell from the original xenograft population during derivation of the HEY cell line. The results presented in this work support this hypothesis, since we have shown that HEY cells display an antigen that is defined by mAb M2A and that likely is also present on a population of testicular and ovarian stem cells that can give rise to the seminoma and dysgerminoma types of tumor, respectively. The antigen was detectable in fetal but not adult testis, presumably because it was lost during normal differentiation of the stem cells. Expression of the antigen by seminomas suggests that these tumors arise by the malignant transformation of a rare stem cell remaining in the adult testis.
The antigen defined by mAb M2A is a monomeric glycoprotein migrating with a molecular weight of approximately 40,000 under both reducing and nonreducing conditions. The three bands visualized by immunoblotting probably represented species with different degrees of glycosylation (Fig. 4  A and B) . The antigen recognized by mAb M2A is present on the cell surface, since the mAb reacted with HEY cells in a cell-binding RIA and the antigen was accessible to enzymatic radioiodination by lactoperoxidase (Figs. 1 and 4C) .
The potential diagnostic importance of mAb M2A is based on its absolute reactivity with seminomas and dysgerminomas and not with other testicular or ovarian tumors or non-testicular or non-ovarian tumors, including those with which seminomas and dysgerminomas might be confused histologically, such as large-cell lymphomas, melanomas, and anaplastic carcinomas. Moreover, since mAb M2A did not stain normal testicular germ cells, it might be of diagnostic value in cases where there is only intratubular spread of seminoma. The histochemical techniques that are presently available for dealing with this problem cannot distinguish between intratubular seminoma cells and other types of normal or abnormal germ cells (16) . It is not known whether all types of seminomas and dysgerminomas will react with mAb M2A, and additional tumors of these types must be examined. However, it is noteworthy that the only seminoma that did not react with mAb M2A in this study was one that was highly anaplastic, was located retroperitoneally, and was not associated with a primary testicular seminoma. Since this tumor was diagnosed solely on the basis of morphologic criteria, the possibility must be considered that it was not a seminoma.
If the antigen recognized by mAb M2A proves to be a specific marker for seminomas and dysgerminomas in a larger series of testicular and ovarian tumors, reactivity with mAb M2A could be a useful diagnostic criterion for primary seminomas and dysgerminomas and their metastases; for metastatic seminomas and dysgerminomas for which no primary can be found; and for extragonadal seminomas and dysgerminomas arising in the mediastinum, retroperitoneum, or central nervous system, especially in cases where diagnosis based on morphologic criteria alone is not conclusive.
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